Comorbidities should be factor in prostate biopsy choice, study finds
UC Irvine Health urologists and health policy experts report in a new study that two written assessments that identify existing comorbidities – the patient-reported Total Illness Burden Index for Prostate Cancer (TIBI-Cap) ...
Cancer
May 15, 2013 |
not rated yet |
0
Study finds gaps in 'decision aids' designed to help determine right cancer screening option
When it comes to a cancer diagnosis, timing can be everything – the sooner it's found, the more treatable it is. But when and how often should someone get screened?
Cancer
May 10, 2013 |
not rated yet |
0
Using genetic variants to improve PSA testing technique and reduce biopsies
With the help of genetics, prostate specific antigen (PSA) screenings may become more accurate and reduce the number of unnecessary prostate biopsies, according to a new study from Northwestern Medicine.
Cancer
Apr 24, 2013 |
5 / 5 (1) |
0
